VISEN Pharmaceuticals disclosed that Non-Executive Director Sherrie Lynn Glass has tendered her resignation, effective 5 October 2026. The departure is attributed to Ms. Glass’s need to allocate more time to other business commitments.

According to the filing, Ms. Glass confirmed she has no disagreements with the Board and is unaware of any matters that should be brought to the attention of shareholders or The Stock Exchange of Hong Kong Limited.

As of the announcement date, VISEN’s Board consists of: • Executive Director – Mr. Lu An-Bang (also Chief Executive Officer) • Non-Executive Directors – Mr. Fu Shan, Mr. Cao Yibo, Mr. Roy Paul Khoury and Mr. Michael J. Chang • Independent Non-Executive Directors – Mr. Chan Peng Kuan, Ms. Ni Hong and Mr. Zhang Qing

The Board expressed its appreciation for Ms. Glass’s contributions during her tenure.